Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization

Background: The goal of this work was to develop a levonorgestrel liposome-loaded microneedle array patch for contraception. Methods: Levonorgestrel-loaded liposome was formulated by a solvent injection technique, characterized, and studied. Results: The formulated liposomes were characterized for p...

Full description

Bibliographic Details
Main Authors: Amarjitsing Rajput, Riyaz Ali M. Osmani, Achyut Khire, Sanket Jaiswal, Rinti Banerjee
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/7/2349
_version_ 1827622922472128512
author Amarjitsing Rajput
Riyaz Ali M. Osmani
Achyut Khire
Sanket Jaiswal
Rinti Banerjee
author_facet Amarjitsing Rajput
Riyaz Ali M. Osmani
Achyut Khire
Sanket Jaiswal
Rinti Banerjee
author_sort Amarjitsing Rajput
collection DOAJ
description Background: The goal of this work was to develop a levonorgestrel liposome-loaded microneedle array patch for contraception. Methods: Levonorgestrel-loaded liposome was formulated by a solvent injection technique, characterized, and studied. Results: The formulated liposomes were characterized for particle size (147 ± 8 nm), polydispersity index (0.207 ± 0.03), zeta potential (−23 ± 4.25 mV), drug loading (18 ± 3.22%) and entrapment efficiency (85 ± 4.34%). A cryo high-resolution transmission electron microscopy and cryo field emission gun scanning electron microscopy study showed spherical shaped particles with a smooth surface. The in vitro drug release and in vivo pharmacokinetic study showed sustained behaviour of Levonorgestrel for 28 days. Conclusion: The levonorgestrel liposome-loaded microneedle array patch showed better contraception than the drug-loaded microneedle array patch.
first_indexed 2024-03-09T11:35:50Z
format Article
id doaj.art-5937a9f69f334b5a84642e5952212dc1
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T11:35:50Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-5937a9f69f334b5a84642e5952212dc12023-11-30T23:43:02ZengMDPI AGMolecules1420-30492022-04-01277234910.3390/molecules27072349Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo CharacterizationAmarjitsing Rajput0Riyaz Ali M. Osmani1Achyut Khire2Sanket Jaiswal3Rinti Banerjee4Nanomedicine Lab, Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai 400076, IndiaNanomedicine Lab, Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai 400076, IndiaNanomedicine Lab, Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai 400076, IndiaNanomedicine Lab, Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai 400076, IndiaNanomedicine Lab, Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai 400076, IndiaBackground: The goal of this work was to develop a levonorgestrel liposome-loaded microneedle array patch for contraception. Methods: Levonorgestrel-loaded liposome was formulated by a solvent injection technique, characterized, and studied. Results: The formulated liposomes were characterized for particle size (147 ± 8 nm), polydispersity index (0.207 ± 0.03), zeta potential (−23 ± 4.25 mV), drug loading (18 ± 3.22%) and entrapment efficiency (85 ± 4.34%). A cryo high-resolution transmission electron microscopy and cryo field emission gun scanning electron microscopy study showed spherical shaped particles with a smooth surface. The in vitro drug release and in vivo pharmacokinetic study showed sustained behaviour of Levonorgestrel for 28 days. Conclusion: The levonorgestrel liposome-loaded microneedle array patch showed better contraception than the drug-loaded microneedle array patch.https://www.mdpi.com/1420-3049/27/7/2349drug deliverynanotechnologycontraceptionlevonorgestrelliposomesmicroneedle
spellingShingle Amarjitsing Rajput
Riyaz Ali M. Osmani
Achyut Khire
Sanket Jaiswal
Rinti Banerjee
Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
Molecules
drug delivery
nanotechnology
contraception
levonorgestrel
liposomes
microneedle
title Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
title_full Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
title_fullStr Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
title_full_unstemmed Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
title_short Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
title_sort levonorgestrel microneedle array patch for sustained release contraception formulation optimization and in vivo characterization
topic drug delivery
nanotechnology
contraception
levonorgestrel
liposomes
microneedle
url https://www.mdpi.com/1420-3049/27/7/2349
work_keys_str_mv AT amarjitsingrajput levonorgestrelmicroneedlearraypatchforsustainedreleasecontraceptionformulationoptimizationandinvivocharacterization
AT riyazalimosmani levonorgestrelmicroneedlearraypatchforsustainedreleasecontraceptionformulationoptimizationandinvivocharacterization
AT achyutkhire levonorgestrelmicroneedlearraypatchforsustainedreleasecontraceptionformulationoptimizationandinvivocharacterization
AT sanketjaiswal levonorgestrelmicroneedlearraypatchforsustainedreleasecontraceptionformulationoptimizationandinvivocharacterization
AT rintibanerjee levonorgestrelmicroneedlearraypatchforsustainedreleasecontraceptionformulationoptimizationandinvivocharacterization